Literature DB >> 36179493

Desmoidfibromatosis of the breast after breast reduction: A case report and a review of the literature.

Youssouf Nabila1, Watik Fedoua2, Sami Zineb1, Houssine Boufettal1, Sakher Mahdaoui1, Naima Samouh1.   

Abstract

INTRODUCTION: Desmoids fibromatosis is a rare pathology whose definitive diagnosis is histological. Although it presents clinical and radiological similarities with breast carcinoma. CASE REPORT: In this observation, we report a case of desmoids fibromatosis diagnosed in a 51-year-old female patient. The positive diagnosis was difficult to retain. DISCUSSION: Desmoids fibromatosis remains a benign pathology with a high recurrence rate and a local aggressiveness requiring an enlarged lumpectomy with sufficient margins up to 3 cm.
CONCLUSION: Radiotherapy remains a therapeutic option in addition to surgery in incomplete sections and in case of multiple recurrences. The place of medical treatments, in particular anti-estrogens, is not clearly defined.
Copyright © 2022. Published by Elsevier Ltd.

Entities:  

Keywords:  Breast; Desmoidfibromatosis; Healthymargin; Recurrence

Year:  2022        PMID: 36179493      PMCID: PMC9568773          DOI: 10.1016/j.ijscr.2022.107681

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  10 in total

1.  Fibrous nodules found at large-core needle biopsy of the breast: imaging features.

Authors:  S C Harvey; C M Denison; S C Lester; P J DiPiro; D N Smith; J E Meyer
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

2.  Dynamic breast MRI in recurrent fibromatosis.

Authors:  Benoît Mesurolle; Isabelle Leconte; Latifa Fellah; Chantal Feger; Takahiko Nakazono; Sho Kudo
Journal:  AJR Am J Roentgenol       Date:  2005-02       Impact factor: 3.959

3.  Primary desmoid tumor (extraabdominal fibromatosis) of the breast.

Authors:  Basak Erguvan-Dogan; Peter J Dempsey; Geetha Ayyar; Michael Z Gilcrease
Journal:  AJR Am J Roentgenol       Date:  2005-08       Impact factor: 3.959

4.  The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.

Authors:  Riaz A Agha; Thomas Franchi; Catrin Sohrabi; Ginimol Mathew; Ahmed Kerwan
Journal:  Int J Surg       Date:  2020-11-09       Impact factor: 6.071

5.  Fibrous lesions of the breast: imaging-pathologic correlation.

Authors:  Neeti B Goel; Thomas E Knight; Shilpa Pandey; Michelle Riddick-Young; Ellen Shaw de Paredes; Ami Trivedi
Journal:  Radiographics       Date:  2005 Nov-Dec       Impact factor: 5.333

Review 6.  Fibromatosis of the breast: case report and current concepts in the management of an uncommon lesion.

Authors:  Graham S Schwarz; Michelle Drotman; Ruth Rosenblatt; Lawrence Milner; Jaime Shamonki; Michael P Osborne
Journal:  Breast J       Date:  2006 Jan-Feb       Impact factor: 2.431

7.  Mammary fibromatosis.

Authors:  Katrina N Glazebrook; Carol A Reynolds
Journal:  AJR Am J Roentgenol       Date:  2009-09       Impact factor: 3.959

8.  Desmoid tumors (fibromatoses) of the breast: a 25-year experience.

Authors:  Heather B Neuman; Edi Brogi; Amber Ebrahim; Murray F Brennan; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2007-09-26       Impact factor: 5.344

Review 9.  [Benign breast tumors: Recommendations of Collège National des Gynécologues Obstétriciens Français (CNGOF)--Short text].

Authors:  V Lavoué; X Fritel; M Antoine; F Beltjens; S Bendifallah; M Boisserie-Lacroix; L Boulanger; G Canlorbe; S Catteau-Jonard; N Chabbert-Buffet; F Chamming's; E Chéreau; J Chopier; C Coutant; J Demetz; N Guilhen; R Fauvet; O Kerdraon; E Laas; G Legendre; C Mathelin; C Nadeau; I Thomassin Naggara; C Ngô; L Ouldamer; A Rafii; M-N Roedlich; J Seror; J-Y Séror; C Touboul; C Uzan; E Daraï
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2015-11-02

Review 10.  Fibromatosis of the male breast: A case report with immunohistochemistry study and review of the literature.

Authors:  Alexandre Henrique Macchetti; Heitor Ricardo Cosiski Marana; Alfredo Ribeiro-Silva; Jurandyr Moreira de Andrade; Carlos Francisco Erbolato Melo
Journal:  Clinics (Sao Paulo)       Date:  2006-08       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.